MXPA04008217A - Derivados funcionales de pentraxin ptx3 grandes para preparar vacuna autologa para tratamiento de tumores. - Google Patents
Derivados funcionales de pentraxin ptx3 grandes para preparar vacuna autologa para tratamiento de tumores.Info
- Publication number
- MXPA04008217A MXPA04008217A MXPA04008217A MXPA04008217A MXPA04008217A MX PA04008217 A MXPA04008217 A MX PA04008217A MX PA04008217 A MXPA04008217 A MX PA04008217A MX PA04008217 A MXPA04008217 A MX PA04008217A MX PA04008217 A MXPA04008217 A MX PA04008217A
- Authority
- MX
- Mexico
- Prior art keywords
- tumours
- treatment
- preparing
- functional derivatives
- long pentraxin
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 2
- 229940037642 autologous vaccine Drugs 0.000 title abstract 2
- 101001082142 Homo sapiens Pentraxin-related protein PTX3 Proteins 0.000 abstract 2
- BFHAYPLBUQVNNJ-UHFFFAOYSA-N Pectenotoxin 3 Natural products OC1C(C)CCOC1(O)C1OC2C=CC(C)=CC(C)CC(C)(O3)CCC3C(O3)(O4)CCC3(C=O)CC4C(O3)C(=O)CC3(C)C(O)C(O3)CCC3(O3)CCCC3C(C)C(=O)OC2C1 BFHAYPLBUQVNNJ-UHFFFAOYSA-N 0.000 abstract 2
- 102100027351 Pentraxin-related protein PTX3 Human genes 0.000 abstract 2
- 210000004881 tumor cell Anatomy 0.000 abstract 2
- 239000012528 membrane Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/4756—Neuregulins, i.e. p185erbB2 ligands, glial growth factor, heregulin, ARIA, neu differentiation factor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5152—Tumor cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Cell Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT2002RM000109A ITRM20020109A1 (it) | 2002-02-28 | 2002-02-28 | Derivati funzionali della pentraxina lunga ptx3 per preparare un vaccino autologo per la cura dei tumori. |
| PCT/IT2003/000104 WO2003072603A2 (en) | 2002-02-28 | 2003-02-25 | Long pentraxin ptx3 functional derivatives for preparing an autologous vaccine for the treatment of tumours |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA04008217A true MXPA04008217A (es) | 2004-11-26 |
Family
ID=11456119
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA04008217A MXPA04008217A (es) | 2002-02-28 | 2003-02-25 | Derivados funcionales de pentraxin ptx3 grandes para preparar vacuna autologa para tratamiento de tumores. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20090110666A1 (https=) |
| EP (1) | EP1478661A2 (https=) |
| JP (1) | JP2005538690A (https=) |
| KR (1) | KR20040099291A (https=) |
| AR (1) | AR038854A1 (https=) |
| AU (1) | AU2003214645A1 (https=) |
| CA (1) | CA2475526A1 (https=) |
| IT (1) | ITRM20020109A1 (https=) |
| MX (1) | MXPA04008217A (https=) |
| PL (1) | PL372719A1 (https=) |
| TW (1) | TWI293958B (https=) |
| WO (1) | WO2003072603A2 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITMI20040858A1 (it) | 2004-04-29 | 2004-07-29 | Farma Dev S R L | Anticorpi monoclonali ibridomi metodo migliorato per determinare la proteina ptx3 e kit per detta determinazione |
| ITRM20040489A1 (it) * | 2004-10-08 | 2005-01-08 | Sigma Tau Ind Farmaceuti | Pentraxina lunga ptx3 deglicosilata o desialidata. |
| JP5427415B2 (ja) * | 2006-01-24 | 2014-02-26 | シグマ−タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニ | Ｆｇｆ２結合性ペプチドおよびそれらの使用 |
| US9226960B2 (en) | 2010-04-16 | 2016-01-05 | Andrew B. Bush | FGF modulation of in vivo antibody production and humoral immunity |
| US8435525B1 (en) * | 2010-04-16 | 2013-05-07 | Andrew B. Bush | FGF modulation of in vivo antibody production and humoral immunity |
| TWI531375B (zh) | 2015-05-29 | 2016-05-01 | 國立成功大學 | 抑制癌細胞活性之短肽治療劑及含此之醫藥組成物 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5849478A (en) * | 1986-08-14 | 1998-12-15 | Cashman; Daniel P. | Blocked-polymerase polynucleotide immunoassay method and kit |
| US5290551A (en) * | 1990-05-08 | 1994-03-01 | Thomas Jefferson University | Treatment of melanoma with a vaccine comprising irradiated autologous melanoma tumor cells conjugated to a hapten |
| IT1298487B1 (it) * | 1997-12-19 | 2000-01-10 | Sigma Tau Ind Farmaceuti | Composizioni farmaceutiche comprendenti pentraxina lunga ptx3 per la terapia di patologie di tipo infettivo, infiammatorio o tumorale, |
| IT1317927B1 (it) * | 2000-11-03 | 2003-07-15 | Sigma Tau Ind Farmaceuti | Uso della pentraxina lunga ptx3 per la preparazione di un medicamentoper il trattamento di patologie autoimmuni. |
| IT1317930B1 (it) * | 2000-11-08 | 2003-07-15 | Sigma Tau Ind Farmaceuti | Uso della pentraxina lunga ptx3 per la preparazione di un medicamentoper il trattamento di patalogie associate ad una alterata attivazione |
| US20020122820A1 (en) * | 2001-01-16 | 2002-09-05 | Hildebrand William H. | Soluble MHC artificial antigen presenting cells |
| US20040198655A1 (en) * | 2001-08-03 | 2004-10-07 | Alberto Mantovani | Use of long pentraxin ptx3 for treating female infertility |
| US7041648B2 (en) * | 2001-08-03 | 2006-05-09 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Compositions and methods for treating female fertility |
| ITRM20020191A1 (it) * | 2002-04-08 | 2003-10-08 | Sigma Tau Ind Farmaceuti | Uso della pentraxina lunga ptx3 per la preparazione di un medicamentoper il trattamento di patologie tumorali associate ad una alterata att |
| US20040137544A1 (en) * | 2002-10-31 | 2004-07-15 | Roberto Latini | PTX3 as an early prognostic indicator of cardiovascular and cerebrovascular pathologies |
| ITRM20030596A1 (it) * | 2003-12-23 | 2005-06-24 | Sigma Tau Ind Farmaceuti | Uso di inibitori della pentraxina lunga ptx3, per la preparazione di un medicamento per la prevenzione e cura di patologie che rispondono all'inibizione dell'attivita' biologica di detta ptx3. |
| US20070023879A1 (en) * | 2005-07-29 | 2007-02-01 | Vinayak Pandey | Single unit heat sink, voltage regulator, and package solution for an integrated circuit |
-
2002
- 2002-02-28 IT IT2002RM000109A patent/ITRM20020109A1/it unknown
-
2003
- 2003-02-20 TW TW092103564A patent/TWI293958B/zh active
- 2003-02-25 AU AU2003214645A patent/AU2003214645A1/en not_active Abandoned
- 2003-02-25 WO PCT/IT2003/000104 patent/WO2003072603A2/en not_active Ceased
- 2003-02-25 JP JP2003571309A patent/JP2005538690A/ja active Pending
- 2003-02-25 CA CA002475526A patent/CA2475526A1/en not_active Abandoned
- 2003-02-25 EP EP03710225A patent/EP1478661A2/en not_active Withdrawn
- 2003-02-25 MX MXPA04008217A patent/MXPA04008217A/es unknown
- 2003-02-25 PL PL03372719A patent/PL372719A1/xx unknown
- 2003-02-25 US US10/506,046 patent/US20090110666A1/en not_active Abandoned
- 2003-02-25 KR KR10-2004-7013464A patent/KR20040099291A/ko not_active Ceased
- 2003-02-27 AR ARP030100642A patent/AR038854A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL372719A1 (en) | 2005-07-25 |
| AR038854A1 (es) | 2005-01-26 |
| TWI293958B (en) | 2008-03-01 |
| ITRM20020109A1 (it) | 2003-08-28 |
| ITRM20020109A0 (it) | 2002-02-28 |
| WO2003072603A2 (en) | 2003-09-04 |
| AU2003214645A1 (en) | 2003-09-09 |
| WO2003072603A3 (en) | 2004-03-18 |
| AU2003214645A8 (en) | 2003-09-09 |
| WO2003072603A9 (en) | 2004-10-07 |
| TW200303755A (en) | 2003-09-16 |
| JP2005538690A (ja) | 2005-12-22 |
| US20090110666A1 (en) | 2009-04-30 |
| CA2475526A1 (en) | 2003-09-04 |
| KR20040099291A (ko) | 2004-11-26 |
| EP1478661A2 (en) | 2004-11-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2018236742B2 (en) | Compositions of adenosine deaminase-2 (ada2), variants thereof and methods of using same | |
| EP2224921A4 (en) | MODULATION OF THE IMMUNE RESPONSE | |
| EP4527466A3 (en) | Anti-dll3 chimeric antigen receptors and uses thereof | |
| DE602006019446D1 (de) | An humane leukozytenantigen-(hla-)klasse-i- oder ii-moleküle bindende tumorassoziierte peptide und damit im zusammenhang stehender impfstoff gegen krebs | |
| CY1115413T1 (el) | Ανασυνδυασμενη fsh η οποια περιλαμβανει αλφα 2,3- και αλφα 2',6-sialylation | |
| WO2020099356A3 (en) | Immunogenic peptides with improved oxidoreductase motifs | |
| NO20065084L (no) | Interferon-alfa polypeptider og konjugater | |
| WO2020257702A8 (en) | Rare earth element (ree)-binding proteins | |
| WO2009059011A3 (en) | Hla-dr binding peptides and their uses | |
| EA202191257A1 (ru) | Противораковая терапия на основе иммуноцитов, связывающих liv1 | |
| IL314996A (en) | Compositions and methods for stimulating natural killer cells | |
| CY1112654T1 (el) | Διαμορφομερη βακτηριακων προσκολλητινων | |
| GEP20105022B (en) | Use of polypeptides of the cupredoxin family in cancer therapy | |
| EA200900738A1 (ru) | Слитые белки, содержащие антигены отторжения опухоли ny-eso-1 и lage-1 | |
| NO20062709L (no) | Stamceller som er egnet for transplantasjon, fremstilling derav og farmasoytiske preperater omfattende nevnte stamceller | |
| EP4252852A3 (en) | Methods and materials for treating cancer | |
| BR112019007365A2 (pt) | métodos e composições para imunoterapia com tusc2 | |
| WO2010056144A3 (en) | Foxp3+ natural kiler t-cells and the treatment of immune related diseases | |
| MXPA04008217A (es) | Derivados funcionales de pentraxin ptx3 grandes para preparar vacuna autologa para tratamiento de tumores. | |
| ZA202100761B (en) | Improvements in immunogenic conjugates | |
| HRP20080612T3 (hr) | Kombinacija tenofovira, ritonavira i tmc114 | |
| MX2021005564A (es) | Metodos y composiciones para inmunoterapia contra cancer. | |
| DE60039306D1 (de) | Nonapeptidische ny-eso-1 derivate und deren verwendung | |
| AR023794A1 (es) | Antigeno asociado con tumores | |
| DK1444261T3 (da) | Immunogene ALK (anaplastisk lymfomakinase) peptider |